The most prevalent genes that were differentially altered in recurrent tumors were the known oncogene DDX5, which has been shown to be frequently amplified in breast cancers [68], and CCNE1, which is frequently amplified in HGSOC [58]. This evidence concerns the gene DDX5 and breast cancer.